EGFR and non-small cell lung carcinoma: The percentage of Asian NSCLC patients with epidermal growth factor receptor (EGFR) mutations is 30%, and the most common mutations are deletions in exon 19 (19-DEL) and the exon 21 codon p.Leu858Arg point (L858R) mutation (7).